EGFR mutation, smoking, and gender in advanced lung adenocarcinoma

PURPOSE: In the current targeted therapy era, information on the effect of smoking in epidermal growth factor receptor (EGFR)-mutant lung cancer patients is scarce. RESULTS: In total, 11,678 adenocarcinoma patients were enrolled. Of these, 33.3% and 91.8% of male and female patients were non-smokers...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Chien-Hua, Chiang, Chun-Ju, Tseng, Jeng-Sen, Yang, Tsung-Ying, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Wang, Chih-Liang, Chen, Chih-Yi, Yen, Sang-Hue, Tsai, Chun-Ming, Huang, Ming-Shyan, Ho, Chao-Chi, Yu, Chong-Jen, Tsai, Ying-Huang, Chen, Jin-Shing, Chou, Teh-Ying, Tsai, Ming-Hsun, Chen, Hsuan-Yu, Su, Kang-Yi, Chen, Jeremy J.W, Chen, Huei-Wen, Yu, Sung-Liang, Liu, Tsang-Wu, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716737/
https://www.ncbi.nlm.nih.gov/pubmed/29228697
http://dx.doi.org/10.18632/oncotarget.21842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716737/
https://www.ncbi.nlm.nih.gov/pubmed/29228697
http://dx.doi.org/10.18632/oncotarget.21842

Ejemplares similares